InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global mRNA Vaccines for Animals Market Size, Share & Trends Analysis Report, By Animal Type (Livestock, and Companion Animals), By Administration Route (Injectable and Non Invasive), By Delivery Technology (Lipid Nanoparticles (LNPs) and Viral Vectors), By Disease Indication (Avian Influenza, Swine Fever, and Canine Diseases), By End User (Veterinary Hospitals & Clinics, Research Institutes, and Farms),-Market Outlook And Industry Analysis 2034″
mRNA Vaccines for Animals Market Size is valued at US$ 80.7 Bn in 2024 and is predicted to reach US$ 7,451.5 Bn by the year 2034 at an 57.6% CAGR during the forecast period for 2025-2034.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/3229
mRNA vaccines for animals are engineered to prevent infectious diseases in livestock, poultry, and companion animals by eliciting precise immune responses without employing live pathogens. These vaccines contribute to enhanced herd immunity, reduced incidence of disease outbreaks, improved productivity, and accelerated, safer vaccine development compared to traditional methods. The market for animal mRNA vaccines is experiencing robust growth, driven by the increasing prevalence of infectious animal diseases, heightened demand for food security, and the need for effective disease prevention across both pets and livestock.
Advancements in mRNA technology facilitate rapid vaccine development with improved safety and scalable production capabilities. Investments by governmental bodies and veterinary organizations in structured immunization programs aim to mitigate economic losses and support enhanced animal husbandry practices. Furthermore, growing awareness of zoonotic disease prevention and the adoption of innovative biotechnological solutions by animal health companies are fueling market expansion. Development of veterinary healthcare infrastructure in emerging markets is also supporting the global uptake and growth of mRNA vaccines for animals.
List of Prominent Players in the mRNA Vaccines for Animals Market:
- Elanco Animal Health
- Boehringer Ingelheim Animal Health
- CureVac AG
- Moderna, Inc.
- GSK (GlaxoSmithKline Animal Health)
- Vaxxas Pty Ltd
- Agenus Inc.
- Tiba Biotech
- Arcturus Therapeutics
- Inovio Pharmaceuticals
Read Overview Report- https://www.insightaceanalytic.com/report/mrna-vaccines-for-animals-market/3229
Market Dynamics
Drivers:
The global market for animal mRNA vaccines is being propelled by rising economic losses resulting from infectious diseases in livestock and companion animals, increasing demand for high-quality animal protein, and the imperative to maintain consistent productivity through effective disease management. mRNA vaccines provide notable advantages over conventional vaccines, including accelerated development timelines, enhanced efficacy, and improved safety profiles.
Advances in technology, such as lipid nanoparticle delivery systems and stabilized formulations, have further strengthened vaccine performance. Support from governmental bodies for animal health research, coupled with investments in veterinary healthcare infrastructure, is further driving market growth. Additionally, growing awareness among farmers and pet owners regarding disease prevention and the mitigation of zoonotic risks presents significant opportunities for mRNA vaccine adoption in the animal health sector.
Challenges:
Market growth is constrained by high production costs and the requirement for specialized cold-chain logistics, which complicates distribution, particularly in developing regions. Prolonged regulatory approval processes for veterinary mRNA vaccines may delay market entry. Furthermore, competition from traditional vaccines and biologics, along with the challenge of scaling production to meet veterinary standards, may impede expansion. Ensuring consistent product quality and maintaining reliable supply chains remain critical challenges for widespread adoption.
Regional Trends:
In 2024, North America, led by the United States, dominated the market for animal mRNA vaccines. Contributing factors include advanced veterinary infrastructure, early adoption of innovative animal health technologies, substantial investment in biotechnology, and government initiatives promoting modern vaccination programs. The presence of leading animal health companies and active R&D efforts, combined with heightened awareness among farmers and pet owners, has facilitated rapid adoption of mRNA vaccines across the region.
The Asia-Pacific region offers significant growth potential, with China and India at the forefront. Rising prevalence of infectious animal diseases, increasing demand for animal protein, supportive government policies, and investments in veterinary healthcare infrastructure, biotechnology-based vaccines, and cold-chain logistics are driving market expansion. Emerging markets in India, China, and Southeast Asia present substantial opportunities for the continued growth of mRNA vaccines in the animal health industry.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customization/3229
Recent Developments:
- July 2025: New South Wales and Tiba Biotech successfully tested an mRNA vaccine for foot-and-mouth disease (FMD) in cattle at Germany’s Friedrich-Loeffler-Institut (FLI). Unlike conventional vaccines, it bypasses high-biosafety virus cultivation and complex antigen purification, simplifying both production and safety.
Segmentation of mRNA Vaccines for Animals Market-
mRNA Vaccines for Animals Market-By Animal Type
- Livestock Animals
- Companion Animals
mRNA Vaccines for Animals Market-By Administration Route
mRNA Vaccines for Animals Market-By Delivery Technology
- Lipid Nanoparticles (LNPs)
- Viral Vectors
mRNA Vaccines for Animals Market-By Disease Indication
- Avian Influenza
- Swine Fever
- Canine Diseases
mRNA Vaccines for Animals Market-By End User
- Veterinary Hospitals & Clinics
- Research Institutes
- Farms
mRNA Vaccines for Animals Market-By Region
North America-
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com
